Feedback
Other Publication
Approvals

FDA Approvals Aug, 2011

This report lists both original approvals and supplemental approvals to NDAs, ANDAs, and BLAs* during the month of August. It includes tentative approvals and original approvals.
Source: www.fda.gov
Drug Name and
FDA Appl. #
Suppl. # Active Ingredients Company Approval Type Approval Date
IRBESARTAN (ANDA # 201531) 000 IRBESARTAN LUPIN LTD Tentative Approval 10/07/2011
METFORMIN HYDROCHLORIDE (ANDA # 200690) 000 METFORMIN HYDROCHLORIDE MYLAN PHARMS INC Tentative Approval 10/27/2011
MONTELUKAST SODIUM (ANDA # 091588) 000 MONTELUKAST SODIUM ENDO PHARMS Tentative Approval 10/27/2011
MONTELUKAST SODIUM (ANDA # 091576) 000 MONTELUKAST SODIUM ENDO PHARMS Tentative Approval 10/27/2011
SOLIFENACIN SUCCINATE (ANDA # 091464) 000 SOLIFENACIN SUCCINATE TEVA PHARMS USA Tentative Approval 10/31/2011
ZOLEDRONIC ACID (ANDA # 091364) 000 ZOLEDRONIC ACID DR REDDYS LABS LTD Tentative Approval 10/31/2011
LAMIVUDINE; ZIDOVUDINE (ANDA # 090246) 000 LAMIVUDINE; ZIDOVUDINE LUPIN LTD Tentative Approval 10/26/2011
CROMOLYN SODIUM (ANDA # 202583) 000 CROMOLYN SODIUM PACK PHARMS LLC Approval 10/27/2011
JUVISYNC (NDA # 202343) 000 SIMVASTATIN; SITAGLIPTIN PHOSPHATE MERCK SHARP DOHME Approval 10/07/2011
FLUOXETINE HYDROCHLORIDE (NDA # 202133) 000 FLUOXETINE HYDROCHLORIDE EDGEMONT PHARMS LLC Approval 10/06/2011
ONFI (NDA # 202067) 000 CLOBAZAM LUNDBECK INC Approval 10/21/2011
Web Counter: